SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

M3, Inc. MTHRY OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • JP • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

M3, Inc. (MTHRY) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $5.05. It has a SharesGrow Score of 77/100, indicating a strong investment profile with 4 out of 7 criteria passed.

Financials: revenue is $284.9B, +11.2%/yr average growth. Net income is $40.5B, growing at -13.8%/yr. Net profit margin is 14.2% (healthy). Gross margin is 54.2% (-2.7 pp trend).

Balance sheet: total debt is $24.4B against $378.4B equity (Debt-to-Equity (D/E) ratio 0.06, conservative). Current ratio is 2.96 (strong liquidity). Debt-to-assets is 4.2%. Total assets: $581.7B.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 48/100 (Partial), Past 100/100 (Pass), Health 100/100 (Pass), Moat 73/100 (Pass), Future ?/100 (Fail), Income 55/100 (Partial).

MTHRY SharesGrow Score Overview

79/100

SharesGrow Score

Strong investment profile

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 48/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 73/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 55/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — MTHRY

MTHRY trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

MTHRY: +11.2%/yr revenue is, -13.8%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

MTHRY: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet MTHRY: Debt-to-Equity (D/E) ratio 0.06 (conservative), Current ratio is 2.96 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

MTHRY: Gross margin is 54.2% (-2.7 pp trend), $7B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 73/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

MTHRY: Net profit margin is 14.2%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range4.73-8.85

Volume12.12K

Avg Volume (30D)692.97K

Market Cap$6.84B

Beta (1Y)0.52

Dividend Yield$0.0700

Share Statistics

EPS (TTM)29.81

Shares Outstanding$1.36B

IPO Date2020-06-29

Employees12,100

CEOItaru Tanimura

Financial Highlights & Ratios

Revenue (TTM)$284.9B

Gross Profit$154.36B

EBITDA$77.71B

Net Income$40.48B

Operating Income$62.97B

Total Cash$166.75B

Total Debt$24.42B

Net Debt$-110.51B

Total Assets$581.74B

Price / Earnings (P/E)0.2

Price / Sales (P/S)0.02

Analyst Forecast

Company Info

CountryJP

ExchangeOther OTC

CurrencyUSD

ISINUS55379N1063

Price Chart

MTHRY

M3, Inc. ↗ · Other OTC

Healthcare • Medical - Healthcare Information Services

4.73 52WK RANGE 8.85

People Also View

HealthEquity, Inc.

Privia Health Group, Inc.

NextGen Healthcare, Inc.

Teladoc Health, Inc.

HealthStream, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message